CN114921502B - Glutaric acid production method for feedback regulation and control of nitrogen source flow based on microorganism physiological parameters - Google Patents
Glutaric acid production method for feedback regulation and control of nitrogen source flow based on microorganism physiological parameters Download PDFInfo
- Publication number
- CN114921502B CN114921502B CN202210426003.6A CN202210426003A CN114921502B CN 114921502 B CN114921502 B CN 114921502B CN 202210426003 A CN202210426003 A CN 202210426003A CN 114921502 B CN114921502 B CN 114921502B
- Authority
- CN
- China
- Prior art keywords
- fermentation
- cer
- glutaric acid
- nitrogen source
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 title claims abstract description 66
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 title claims abstract description 56
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 title claims abstract description 54
- 229910052757 nitrogen Inorganic materials 0.000 title claims abstract description 33
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 31
- 230000009123 feedback regulation Effects 0.000 title claims abstract description 5
- 244000005700 microbiome Species 0.000 title abstract description 8
- 238000000855 fermentation Methods 0.000 claims abstract description 84
- 230000004151 fermentation Effects 0.000 claims abstract description 84
- 230000001133 acceleration Effects 0.000 claims abstract description 20
- 239000001963 growth medium Substances 0.000 claims abstract description 14
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000001569 carbon dioxide Substances 0.000 claims abstract description 6
- 229910002092 carbon dioxide Inorganic materials 0.000 claims abstract description 6
- 230000036284 oxygen consumption Effects 0.000 claims abstract description 3
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims description 26
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims description 26
- 235000011130 ammonium sulphate Nutrition 0.000 claims description 26
- 238000000034 method Methods 0.000 claims description 19
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 15
- 239000008103 glucose Substances 0.000 claims description 15
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 14
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 14
- 230000000813 microbial effect Effects 0.000 claims description 14
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 11
- 229960000723 ampicillin Drugs 0.000 claims description 9
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 claims description 9
- 229960005091 chloramphenicol Drugs 0.000 claims description 9
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 claims description 9
- 239000002609 medium Substances 0.000 claims description 9
- 241000588724 Escherichia coli Species 0.000 claims description 8
- 238000012269 metabolic engineering Methods 0.000 claims description 8
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 8
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 8
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 7
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 239000003242 anti bacterial agent Substances 0.000 claims description 5
- 229940088710 antibiotic agent Drugs 0.000 claims description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 5
- 238000011081 inoculation Methods 0.000 claims description 5
- 229930027917 kanamycin Natural products 0.000 claims description 5
- 229960000318 kanamycin Drugs 0.000 claims description 5
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 claims description 5
- 229930182823 kanamycin A Natural products 0.000 claims description 5
- 239000001301 oxygen Substances 0.000 claims description 5
- 229910052760 oxygen Inorganic materials 0.000 claims description 5
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims description 4
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 claims description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims description 4
- 229930003451 Vitamin B1 Natural products 0.000 claims description 4
- 240000008042 Zea mays Species 0.000 claims description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 4
- 239000001099 ammonium carbonate Substances 0.000 claims description 4
- 229960003237 betaine Drugs 0.000 claims description 4
- 235000005822 corn Nutrition 0.000 claims description 4
- 229960003495 thiamine Drugs 0.000 claims description 4
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 4
- 239000011691 vitamin B1 Substances 0.000 claims description 4
- 235000010374 vitamin B1 Nutrition 0.000 claims description 4
- 239000011790 ferrous sulphate Substances 0.000 claims description 3
- 235000003891 ferrous sulphate Nutrition 0.000 claims description 3
- 229910000359 iron(II) sulfate Inorganic materials 0.000 claims description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 3
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 3
- 229940099596 manganese sulfate Drugs 0.000 claims description 3
- 239000011702 manganese sulphate Substances 0.000 claims description 3
- 235000007079 manganese sulphate Nutrition 0.000 claims description 3
- 230000001105 regulatory effect Effects 0.000 claims description 3
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 claims description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 2
- 235000012538 ammonium bicarbonate Nutrition 0.000 claims description 2
- 235000012501 ammonium carbonate Nutrition 0.000 claims description 2
- 235000019270 ammonium chloride Nutrition 0.000 claims description 2
- 239000004202 carbamide Substances 0.000 claims description 2
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 claims 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 claims 1
- 239000002253 acid Substances 0.000 abstract description 23
- 238000006243 chemical reaction Methods 0.000 abstract description 5
- 238000013341 scale-up Methods 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 27
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 14
- 239000004472 Lysine Substances 0.000 description 9
- 230000001580 bacterial effect Effects 0.000 description 9
- JJMDCOVWQOJGCB-UHFFFAOYSA-N 5-aminopentanoic acid Chemical compound [NH3+]CCCCC([O-])=O JJMDCOVWQOJGCB-UHFFFAOYSA-N 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 230000003115 biocidal effect Effects 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 241000186226 Corynebacterium glutamicum Species 0.000 description 7
- 238000011160 research Methods 0.000 description 7
- 238000003786 synthesis reaction Methods 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 6
- 230000037361 pathway Effects 0.000 description 6
- 235000019766 L-Lysine Nutrition 0.000 description 5
- 230000001276 controlling effect Effects 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- WRUGWIBCXHJTDG-UHFFFAOYSA-L magnesium sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Mg+2].[O-]S([O-])(=O)=O WRUGWIBCXHJTDG-UHFFFAOYSA-L 0.000 description 5
- 229940061634 magnesium sulfate heptahydrate Drugs 0.000 description 5
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 4
- 239000001888 Peptone Substances 0.000 description 4
- 108010080698 Peptones Proteins 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 4
- 229910021529 ammonia Inorganic materials 0.000 description 4
- 235000018977 lysine Nutrition 0.000 description 4
- 235000019319 peptone Nutrition 0.000 description 4
- 239000013612 plasmid Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000009423 ventilation Methods 0.000 description 4
- 108030002022 Lysine 2-monooxygenases Proteins 0.000 description 3
- 241000589776 Pseudomonas putida Species 0.000 description 3
- 102000005566 Succinate-Semialdehyde Dehydrogenase Human genes 0.000 description 3
- 108010084086 Succinate-Semialdehyde Dehydrogenase Proteins 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- SURQXAFEQWPFPV-UHFFFAOYSA-L iron(2+) sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Fe+2].[O-]S([O-])(=O)=O SURQXAFEQWPFPV-UHFFFAOYSA-L 0.000 description 3
- ISPYRSDWRDQNSW-UHFFFAOYSA-L manganese(II) sulfate monohydrate Chemical compound O.[Mn+2].[O-]S([O-])(=O)=O ISPYRSDWRDQNSW-UHFFFAOYSA-L 0.000 description 3
- 241000894007 species Species 0.000 description 3
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 2
- 108010073590 5-aminovalerate aminotransferase Proteins 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 239000001361 adipic acid Substances 0.000 description 2
- 235000011037 adipic acid Nutrition 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000011217 control strategy Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000009615 deamination Effects 0.000 description 2
- 238000006481 deamination reaction Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000011218 seed culture Methods 0.000 description 2
- 238000012807 shake-flask culturing Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- OTIAVLWNTIXJDO-UHFFFAOYSA-N 5-aminopentanamide Chemical compound NCCCCC(N)=O OTIAVLWNTIXJDO-UHFFFAOYSA-N 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- XKMRRTOUMJRJIA-UHFFFAOYSA-N ammonia nh3 Chemical compound N.N XKMRRTOUMJRJIA-UHFFFAOYSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
- 229930188620 butyrolactone Natural products 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000012364 cultivation method Methods 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- VANNPISTIUFMLH-UHFFFAOYSA-N glutaric anhydride Chemical compound O=C1CCCC(=O)O1 VANNPISTIUFMLH-UHFFFAOYSA-N 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000004941 influx Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000007142 ring opening reaction Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 238000005891 transamination reaction Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/44—Polycarboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/15—Corynebacterium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/185—Escherichia
- C12R2001/19—Escherichia coli
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
技术领域Technical field
本发明属于生物领域,特别涉及一种基于微生物生理参数反馈调控氮源流加的戊二酸生产方法。The invention belongs to the field of biology, and in particular relates to a glutaric acid production method based on feedback control of nitrogen source feeding based on microbial physiological parameters.
背景技术Background technique
戊二酸可以合成戊二酸酐,广泛应用于橡胶、医药等领域。此外,戊二酸与不同的二元胺聚合可以得到新型的聚酰胺。目前,市场上的戊二酸大多是通过分离己二酸的副产物或者通过化学反应得到。化学合成戊二酸需要高温、高压和昂贵的催化剂,如通过丁内酯与剧毒化合物氰化钾开环,然后进行水解反应可以合成戊二酸,该工艺毒性大、成本高、工艺安全性低、环境不友好。通过分离己二酸的副产物来得到高纯度戊二酸需要多步结晶、收率低、成本高,限制了戊二酸的进一步应用。近年来,通过代谢工程改造微生物生产戊二酸成为研究的热点,包括大肠杆菌和谷氨酸棒杆菌在内的微生物被广泛开发合成戊二酸。5-氨基戊酸途径(AMV)途径被以为是最有指望的戊二酸生物合成途径。如图1所示,AMV途径是通过选择合适的宿主,如大肠杆菌或者谷氨酸棒杆菌,在其中过表达来源于恶臭假单胞菌(Pseudomonas putida)的赖氨酸2-单加氧酶(DavB)和δ-氨基戊酰胺酶(DavA),将赖氨酸代谢为5-氨基戊酸,再进一步通过5-氨基戊酸氨基转移酶(GabT)和琥珀酸半醛脱氢酶(GabD)得到戊二酸。迄今为止,生物法合成戊二酸的研究主要集中于对微生物的代谢工程改造,而对戊二酸的发酵工艺研究甚少。工业生产L-赖氨酸的微生物生产需要大量的氮源,如硫酸铵和液氨,而基于L-赖氨酸分解代谢的戊二酸生产需要逐步的脱氨和转氨反应。因此,氮源流加策略会干扰L-赖氨酸和戊二酸的合成,然而,没有相关文献报道氮源如何影响戊二酸的合成。同样如图1所示,L-赖氨酸到5-氨基戊酰胺需要氧气并产生二氧化碳,这与实时的微生物摄氧率(OUR)、二氧化碳释放率(CER)生理参数有关。本发明中,我们开发了一种基于实时的微生物生理参数进行反馈调节的氮源流加策略,并应用于戊二酸的生物法生产。该工艺产酸高,糖酸转化率高,容易放大到产业化规模。Glutaric acid can be synthesized into glutaric anhydride, which is widely used in rubber, medicine and other fields. In addition, new polyamides can be obtained by polymerizing glutaric acid with different diamines. Currently, most of the glutaric acid on the market is obtained by separating the by-products of adipic acid or through chemical reactions. Chemical synthesis of glutaric acid requires high temperature, high pressure, and expensive catalysts. For example, glutaric acid can be synthesized by ring-opening butyrolactone with the highly toxic compound potassium cyanide, and then performing a hydrolysis reaction. This process is highly toxic, costly, and process-safe. Low and environmentally unfriendly. Obtaining high-purity glutaric acid by separating the by-products of adipic acid requires multi-step crystallization, low yield, and high cost, which limits the further application of glutaric acid. In recent years, metabolic engineering of microorganisms to produce glutaric acid has become a hot research topic, and microorganisms including Escherichia coli and Corynebacterium glutamicum have been widely developed to synthesize glutaric acid. The 5-aminovaleric acid pathway (AMV) pathway is considered the most promising glutaric acid biosynthetic pathway. As shown in Figure 1, the AMV pathway is achieved by selecting a suitable host, such as Escherichia coli or Corynebacterium glutamicum, in which the lysine 2-monooxygenase derived from Pseudomonas putida is overexpressed. (DavB) and δ-aminovaleramidase (DavA), metabolize lysine into 5-aminovaleric acid, which is further metabolized by 5-aminovaleric acid aminotransferase (GabT) and succinate semialdehyde dehydrogenase (GabD) ) to obtain glutaric acid. So far, research on the biological synthesis of glutaric acid has mainly focused on the metabolic engineering of microorganisms, while little research has been done on the fermentation process of glutaric acid. Microbial production of industrial L-lysine requires large amounts of nitrogen sources, such as ammonium sulfate and liquid ammonia, while glutaric acid production based on L-lysine catabolism requires stepwise deamination and transamination reactions. Therefore, the nitrogen source fed-batch strategy will interfere with the synthesis of L-lysine and glutaric acid. However, there is no relevant literature reporting how the nitrogen source affects the synthesis of glutaric acid. Also shown in Figure 1, L-lysine to 5-aminovaleramide requires oxygen and produces carbon dioxide, which is related to the real-time physiological parameters of microbial oxygen uptake rate (OUR) and carbon dioxide release rate (CER). In the present invention, we developed a nitrogen source feeding strategy based on feedback regulation of real-time microbial physiological parameters, and applied it to the biological production of glutaric acid. This process has high acid production and high sugar-acid conversion rate, and can be easily scaled up to industrial scale.
发明内容Contents of the invention
针对现有技术的缺陷,本发明所要解决的技术问题是提供一种基于微生物生理参数进行反馈调控氮源流加的戊二酸生产方法。In view of the shortcomings of the existing technology, the technical problem to be solved by the present invention is to provide a glutaric acid production method that uses feedback control of nitrogen source feeding based on microbial physiological parameters.
本发明的一种基于微生物生理参数进行反馈调控氮源流加的戊二酸生产方法,包括:The present invention provides a glutaric acid production method based on feedback control of nitrogen source feeding based on microbial physiological parameters, including:
将菌种接种于含有发酵培养基的发酵罐内,以实时的微生物生理参数为依据反馈调控氮源流加,进行发酵获得戊二酸;其中,微生物生理参数包括氧气消耗速率(OUR)、二氧化碳生成速率(CER)。The bacteria are inoculated into the fermentation tank containing the fermentation medium, and the nitrogen source is fed back and regulated based on real-time microbial physiological parameters to ferment to obtain glutaric acid. Among them, the microbial physiological parameters include oxygen consumption rate (OUR) and carbon dioxide production. rate (CER).
进一步地,将戊二酸生产菌培养液接种于含有发酵培养基的发酵罐内,在合适的培养基和培养条件下,微生物利用培养基生长,当实时的OUR、CER逐步上升到140–180m molL-1h-1,微生物进入戊二酸快速合成阶段,在该时,启动氮源流加。Further, the culture solution of glutaric acid-producing bacteria is inoculated into the fermentation tank containing the fermentation medium. Under the appropriate medium and culture conditions, the microorganisms use the medium to grow. When the real-time OUR and CER gradually rise to 140-180m molL -1 h -1 , the microorganism enters the rapid synthesis stage of glutaric acid. At this time, the nitrogen source feeding is started.
所述调控氮源流加为调控氮源流加的速度,氮源流加的速度可以基于实时的OUR、CER自动反馈调节,也可以根据实时的OUR、CER手动调节。The control of nitrogen source flow addition is to regulate the speed of nitrogen source flow addition. The speed of nitrogen source flow addition can be automatically adjusted based on real-time OUR and CER feedback, or can be manually adjusted based on real-time OUR and CER.
进一步地,当产酸期的OUR、CER低于140–180m mol L-1h-1,提高氮源流加速度,使得OUR、CER保持在140–180m mol L-1h-1,更优选为160–180m mol L-1h-1。Further, when the OUR and CER during the acid production period are lower than 140-180m mol L -1 h -1 , the nitrogen source flow acceleration is increased to keep the OUR and CER at 140-180m mol L -1 h -1 , more preferably 160 –180m mol L -1 h -1 .
所述氮源为氨水、液氨、硫酸铵溶液、氯化铵溶液、尿素溶液、碳酸铵、碳酸氢铵溶液中的一种或几种,优选为硫酸铵溶液,其中,所述的溶液为水溶液。The nitrogen source is one or more of ammonia, liquid ammonia, ammonium sulfate solution, ammonium chloride solution, urea solution, ammonium carbonate, ammonium bicarbonate solution, preferably ammonium sulfate solution, wherein the solution is aqueous solution.
当用氨水进行氮源流加时,可以同时用氨水来调控发酵液的pH值,使得pH值保持在6.7–7.2,也可以用氢氧化钠溶液来调控发酵液的pH值,氨水的浓度一般在25–28%(w/v),氢氧化钠溶液的浓度一般在5–40%(w/v)。When using ammonia water for nitrogen source flow, you can use ammonia water to adjust the pH value of the fermentation liquid at the same time to keep the pH value at 6.7-7.2. You can also use sodium hydroxide solution to control the pH value of the fermentation liquid. The concentration of ammonia water is generally between 25–28% (w/v), the concentration of sodium hydroxide solution is generally 5–40% (w/v).
进一步优选地,流加10–50%(w/v)的硫酸铵溶液提供氮源,5–40%(w/v)氢氧化钠溶液调控发酵液的pH值为6.7–7.2。Further preferably, 10-50% (w/v) ammonium sulfate solution is fed to provide a nitrogen source, and 5-40% (w/v) sodium hydroxide solution is added to regulate the pH value of the fermentation broth to 6.7-7.2.
所述发酵过程中还包括流加葡萄糖溶液,使得发酵液中葡萄糖的浓度为0.5–1%(w/v)。所述流加葡萄糖溶液,其中葡萄糖溶液的浓度为50–70%(w/v)。The fermentation process also includes feeding glucose solution so that the concentration of glucose in the fermentation broth is 0.5-1% (w/v). The glucose solution is fed, wherein the concentration of the glucose solution is 50-70% (w/v).
所述发酵工艺参数包括:接种量10–20%,发酵温度35–37℃,控制发酵液pH值为6.7–7.2,搅拌转速和溶氧(DO)关联,使得DO维持在20–40%,罐压保持在0.05–0.1MPa,发酵周期为50–70h。The fermentation process parameters include: inoculation amount 10-20%, fermentation temperature 35-37°C, controlling the pH value of the fermentation liquid to 6.7-7.2, and linking the stirring speed to dissolved oxygen (DO) to maintain DO at 20-40%. The tank pressure is maintained at 0.05–0.1MPa, and the fermentation cycle is 50–70h.
所述发酵采用的培养基为:磷酸二氢钾3–8g/L,1–3g/L硫酸镁、0.01–0.03g/L硫酸亚铁、0.01–0.04g/L硫酸锰、5–15g/L硫酸铵、20–40g/L葡萄糖、5–30g/L玉米浆,0.5–3g/L甜菜碱,0.002–0.006g/L维生素B1、培养基中添加抗生素,其中所述抗生素为30–200μg/mL氨苄青霉素、30–100μg/mL氯霉素、30–200μg/mL卡那霉素的一种或者几种。The culture medium used for the fermentation is: potassium dihydrogen phosphate 3-8g/L, 1-3g/L magnesium sulfate, 0.01-0.03g/L ferrous sulfate, 0.01-0.04g/L manganese sulfate, 5-15g/L L ammonium sulfate, 20-40g/L glucose, 5-30g/L corn steep liquor, 0.5-3g/L betaine, 0.002-0.006g/L vitamin B1, antibiotics are added to the culture medium, wherein the antibiotic is 30-200μg /mL ampicillin, 30-100μg/mL chloramphenicol, 30-200μg/mL kanamycin or one or more.
所述菌种为代谢工程改造的大肠杆菌或谷氨酸棒杆菌。The bacterial strain is metabolically engineered Escherichia coli or Corynebacterium glutamicum.
注:本发明中的质量体积百分比%(w/v)均为g/100ml。Note: The mass volume percentage (w/v) in the present invention is all g/100ml.
进一步地,本实验采用的戊二酸生产菌为代谢工程菌株。戊二酸代谢工程菌的相关研究报道较多。基于AMV途径的戊二酸生产菌的改造,主要通过将含有来自于恶臭假单胞菌的的赖氨酸2-单加氧酶(DavB)编码基因和δ-氨基戊酰胺酶(DavA)编码基因的质粒转入宿主菌,并进一步通过质粒过表达5-氨基戊酸氨基转移酶(GabT)和琥珀酸半醛脱氢酶(GabD,得到戊二酸。赖氨酸是合成戊二酸的前体,因此增强赖氨酸的代谢流也是常用的手段。目前,戊二酸生产菌大多为改造的大肠杆菌或者谷氨酸棒杆菌。如Han等人的研究报告Glutaric acid production by systems metabolic engineering of an L-lysine–overproducing Corynebacterium glutamicum(2020,Pnas.117,30328-30334),Kim等人的研究报告Metabolic engineering of Corynebacterium glutamicum for theproduction of glutaric acid,a C5 dicarboxylic acid platformchemical(2019,Metab.Eng.51,99–109),Li等人的研究报告Targeting metabolic driving andintermediate influx in L-lysine catabolism for high-level glutarateproduction.(2019,Nat.Commun.10,3337),Rohles等人的研究报告Systems metabolicengineering of Corynebacterium glutamicum for the production of the carbon-5platform chemicals 5-aminovalerate and glutarate.(2016,Microb.Cell.Fact.15,1-13),Adkins等人的研究报告Engineering Escherichia coli for RenewableProduction of the 5-Carbon Polyamide Building-Blocks 5-Aminovalerate andGlutarate(2013,Biotechnol.Bioeng.110,1726-1734)。Furthermore, the glutaric acid-producing bacteria used in this experiment are metabolically engineered strains. There are many reports on glutaric acid metabolism engineering bacteria. The modification of glutaric acid-producing bacteria based on the AMV pathway mainly involves the encoding of lysine 2-monooxygenase (DavB) and δ-aminovaleramidase (DavA) from Pseudomonas putida. The gene plasmid is transferred into the host bacteria, and 5-aminovalerate aminotransferase (GabT) and succinic semialdehyde dehydrogenase (GabD) are further overexpressed through the plasmid to obtain glutaric acid. Lysine is used to synthesize glutaric acid. Precursor, therefore enhancing the metabolic flux of lysine is also a common method. At present, glutaric acid-producing bacteria are mostly modified Escherichia coli or Corynebacterium glutamicum. For example, the research report of Han et al. Glutaric acid production by systems metabolic engineering of an L-lysine–overproducing Corynebacterium glutamicum(2020,Pnas.117,30328-30334), Kim et al.’s research report Metabolic engineering of Corynebacterium glutamicum for theproduction of glutaric acid,a C5 dicarboxylic acid platformchemical(2019,Metab.Eng. 51,99–109), Li et al.’s research report Targeting metabolic driving and intermediate influx in L-lysine catabolism for high-level glutarateproduction. (2019, Nat. Commun. 10, 3337), Rohles et al. Systems metabolic engineering of Corynebacterium glutamicum for the production of the carbon-5platform chemicals 5-aminovalerate and glutarate. (2016, Microb.Cell.Fact.15,1-13), Adkins et al. Research report Engineering Escherichia coli for RenewableProduction of the 5-Carbon Polyamide Building-Blocks 5-Aminovalerate and Glutarate (2013, Biotechnol. Bioeng. 110, 1726-1734).
进一步地,以本发明人所在实验室基于AMV途径参考上述文献构建的代谢工程菌株Escherichia coli LQ-1合成戊二酸为例来阐述该过程,权利要求不限于本实验室菌种、相关培养基和培养方法。Further, this process will be explained by taking the metabolic engineering strain Escherichia coli LQ-1 constructed by the inventor's laboratory based on the AMV pathway and referring to the above-mentioned literature to synthesize glutaric acid as an example to illustrate this process. The claims are not limited to the laboratory strains and related culture media. and cultivation methods.
生物法戊二酸发酵包括甘油管种子活化、摇瓶种子培养、种子罐种子培养和发酵过程。Biological glutaric acid fermentation includes seed activation in glycerol tubes, seed culture in shake flasks, seed culture in seed tanks and fermentation processes.
甘油管自然解冻后,用消毒后的枪头取300uL于平板培养基上,尽量铺开,37℃恒温培养箱倒置培养24h,平板培养基为:4–10g/L磷酸二氢钾、0.3–1g/L七水硫酸镁、2–6g/L硫酸铵、1–5g/L酵母粉、5–10g/L蛋白胨、1–5g/L蔗糖,添加合适的抗生素,如30–200μg/mL氨苄青霉素、30–100μg/mL氯霉素、30–200μg/mL卡那霉素的一种或者几种。抗生素种类的添加取决于代谢工程菌株的抗生素抗性特征。平板上菌落形成菌苔,用接种环取整个平板菌体于种子摇瓶中,种子摇瓶培养基同平板培养基,37℃,170rpm摇床培养7h后,接种一级种子罐。After the glycerin tube is naturally thawed, use a sterilized pipette tip to take 300uL on the plate culture medium, spread it as much as possible, and incubate it upside down in a 37°C constant temperature incubator for 24 hours. The plate culture medium is: 4–10g/L potassium dihydrogen phosphate, 0.3– 1g/L magnesium sulfate heptahydrate, 2–6g/L ammonium sulfate, 1–5g/L yeast powder, 5–10g/L peptone, 1–5g/L sucrose, add appropriate antibiotics, such as 30–200μg/mL ampicillin One or more of penicillin, 30–100 μg/mL chloramphenicol, and 30–200 μg/mL kanamycin. The addition of antibiotic species depends on the antibiotic resistance characteristics of the metabolically engineered strain. The bacterial colonies on the plate form a bacterial lawn. Use an inoculating loop to take the entire bacterial plate and put it into a seed shake flask. The seed shake flask culture medium is the same as the plate culture medium. After culturing for 7 hours on a shaking table at 37°C and 170 rpm, inoculate the first-level seed tank.
一级种子罐的接种量0.1–1%,通风量0.4–0.6vvm,搅拌转速300–600rpm,罐压0.05–0.08MPa,发酵过程中控制DO>5%,发酵过程pH值控制为6.7–7.2,37℃,培养16–18h,OD600达到0.8–1.0(稀释25倍)后,接种于10L的种子罐中,种子罐培养基为4–10g/L磷酸二氢钾、0.3–1g/L七水硫酸镁、2–6g/L硫酸铵、1–5g/L酵母粉、5–10g/L蛋白胨、30–50g/L葡萄糖、30–100μg/mL氨苄青霉素、30–100μg/mL氯霉素。选择合适的抗生素,如30–200μg/mL氨苄青霉素、30–100μg/mL氯霉素、30–200μg/mL卡那霉素的一种或者几种。抗生素种类的添加取决于代谢工程菌株的抗生素抗性特征。The inoculum volume of the first-level seed tank is 0.1–1%, the ventilation volume is 0.4–0.6vvm, the stirring speed is 300–600rpm, the tank pressure is 0.05–0.08MPa, the DO is controlled to be >5% during the fermentation process, and the pH value during the fermentation process is controlled at 6.7–7.2. , 37℃, culture for 16-18h, after the OD 600 reaches 0.8-1.0 (diluted 25 times), inoculate into a 10L seed tank. The seed tank culture medium is 4-10g/L potassium dihydrogen phosphate, 0.3-1g/L Magnesium sulfate heptahydrate, 2–6g/L ammonium sulfate, 1–5g/L yeast powder, 5–10g/L peptone, 30–50g/L glucose, 30–100μg/mL ampicillin, 30–100μg/mL chloramphenicol white. Choose an appropriate antibiotic, such as one or more of 30–200 μg/mL ampicillin, 30–100 μg/mL chloramphenicol, and 30–200 μg/mL kanamycin. The addition of antibiotic species depends on the antibiotic resistance characteristics of the metabolically engineered strain.
发酵工艺为接种量10–20%,通风量0.4–0.5vvm,搅拌转速300–800rpm,罐压0.05–0.1MPa,控制发酵过程中DO>20%,控制发酵过程pH值6.7–7.2,发酵过程中,流加50–70%的葡萄糖溶液,并控制发酵液残糖浓度在0.5–1%,发酵周期为50–70h。发酵培养基包括:磷酸二氢钾3–8g/L,1–3g/L硫酸镁、0.01–0.03g/L硫酸亚铁、0.01–0.04g/L硫酸锰、5–15g/L硫酸铵、20–40g/L葡萄糖、5–30g/L玉米浆,0.5–3g/L甜菜碱,0.002–0.006g/L维生素B1,选择合适的抗生素,如30–200μg/mL氨苄青霉素、30–100μg/mL氯霉素、30–200μg/mL卡那霉素的一种或者几种。抗生素种类的添加取决于代谢工程菌株的抗生素抗性特征。The fermentation process is as follows: inoculation amount 10–20%, ventilation volume 0.4–0.5vvm, stirring speed 300–800rpm, tank pressure 0.05–0.1MPa, controlling DO>20% during the fermentation process, controlling the pH value during the fermentation process 6.7–7.2, and controlling the fermentation process. , add 50-70% glucose solution, and control the residual sugar concentration of the fermentation broth to 0.5-1%, and the fermentation cycle is 50-70h. Fermentation medium includes: potassium dihydrogen phosphate 3–8g/L, 1–3g/L magnesium sulfate, 0.01–0.03g/L ferrous sulfate, 0.01–0.04g/L manganese sulfate, 5–15g/L ammonium sulfate, 20–40g/L glucose, 5–30g/L corn steep liquor, 0.5–3g/L betaine, 0.002–0.006g/L vitamin B1, choose appropriate antibiotics, such as 30–200μg/mL ampicillin, 30–100μg/ mL chloramphenicol, 30-200 μg/mL kanamycin, or one or more. The addition of antibiotic species depends on the antibiotic resistance characteristics of the metabolically engineered strain.
进一步地,采用气相色谱法测定发酵液中的戊二酸含量,具体为发酵液取样后,离心机5000rpm离心5分钟,取上清液进行测定。气相色谱仪为GC2010pro(SHIMADZU,Japan),自动进样器,进样量0.5μL,分流比20:1。进口温度290℃,载气流速1.2mL/min,,检测器FID设定温度320℃。色谱柱起始温度为180℃,维持2分钟,以每分钟15℃的速率升温至300℃,维持7分钟。色谱柱型号为Wondacap-5:30m◇0.25mm◇0.25μm。Further, gas chromatography was used to determine the glutaric acid content in the fermentation broth. Specifically, after sampling the fermentation broth, centrifuge at 5000 rpm for 5 minutes, and take the supernatant for measurement. The gas chromatograph is GC2010pro (SHIMADZU, Japan), automatic sampler, injection volume 0.5 μL, split ratio 20:1. The inlet temperature is 290°C, the carrier gas flow rate is 1.2mL/min, and the detector FID setting temperature is 320°C. The initial temperature of the chromatographic column was 180°C, maintained for 2 minutes, raised to 300°C at a rate of 15°C per minute, and maintained for 7 minutes. The column model is Wondacap-5:30m◇0.25mm◇0.25μm.
进一步地,菌体生物量用分光光度计测定600nm下的吸光值,采用OD600来表示。发酵液的氨氮浓度采用常规凯氏定氮法测定。发酵液中的中间体赖氨酸采用常规的茚三酮比色法来测定。Furthermore, the bacterial biomass was measured by the absorbance value at 600 nm using a spectrophotometer, and expressed as OD 600 . The ammonia nitrogen concentration of the fermentation broth was determined by the conventional Kjeldahl nitrogen determination method. The intermediate lysine in the fermentation broth was determined by the conventional ninhydrin colorimetric method.
进一步地,发酵过程中,利用在线尾气分析仪检测尾气中的二氧化碳和氧气含量,利用国强生化设备公司FUS-30L高级发酵罐所带的biostar软件在线采集DO、CER、OUR、RQ等过程参数。Furthermore, during the fermentation process, an online exhaust gas analyzer was used to detect the carbon dioxide and oxygen content in the exhaust gas, and the biostar software included in the FUS-30L advanced fermentation tank of Guoqiang Biochemical Equipment Company was used to collect process parameters such as DO, CER, OUR, and RQ online. .
有益效果beneficial effects
本发明基于发酵过程中的在线微生物生理特性参数OUR、CER指导的氮源调控策略在生物法戊二酸中的应用,采用该方法戊二酸产量高、糖酸转化率高,容易进行规模化放大。The present invention is based on the application of nitrogen source control strategy guided by online microbial physiological characteristic parameters OUR and CER in the fermentation process in biological glutaric acid. This method has high glutaric acid yield, high sugar acid conversion rate, and is easy to scale up. enlarge.
附图说明Description of the drawings
图1为基于AMV途径的戊二酸合成过程中的脱氨、脱羧反应。Figure 1 shows the deamination and decarboxylation reactions in the glutaric acid synthesis process based on the AMV pathway.
图2为仅流加25%氨水,控制氨水流加速度,使得产酸期OUR、CER在60–80m mol L- 1h-1的戊二酸实时发酵过程参数图。Figure 2 is a parameter diagram of glutaric acid real-time fermentation process in which only 25% ammonia water is added and the ammonia water flow acceleration is controlled so that the OUR and CER in the acid production period are 60–80m mol L - 1 h -1 .
图3为用30%氢氧化钠溶液调控发酵液pH,控制25%氨水流加速度,使得产酸期OUR、CER在120–140m mol L-1h-1的戊二酸实时发酵过程参数图。Figure 3 is a parameter diagram of glutaric acid real-time fermentation process using 30% sodium hydroxide solution to adjust the pH of the fermentation broth and control the acceleration of 25% ammonia water flow so that the OUR and CER during the acid production period are 120–140m mol L -1 h -1 .
图4为流加50%硫酸铵溶液,控制硫酸铵流加速度,使得产酸前期OUR和CER保持在160–180m mol L-1h-1,产酸中后期OUR和CER保持在60–80m mol L-1h-1的戊二酸实时发酵过程参数图。Figure 4 shows the feeding of 50% ammonium sulfate solution, and the ammonium sulfate flow acceleration is controlled so that OUR and CER are maintained at 160–180m mol L -1 h -1 in the early stage of acid production, and OUR and CER are maintained at 60–80m mol in the middle and late stages of acid production. L -1 h -1 glutaric acid real-time fermentation process parameter diagram.
图5为流加50%硫酸铵溶液,控制硫酸铵流加速度,使得产酸前期OUR和CER保持在140–160m mol L-1h-1,产酸中后期OUR和CER保持在80–100m mol L-1h-1的戊二酸实时发酵过程参数图。Figure 5 shows the feeding of 50% ammonium sulfate solution, and the ammonium sulfate flow acceleration is controlled so that OUR and CER are maintained at 140–160m mol L -1 h -1 in the early stage of acid production, and OUR and CER are maintained at 80–100m mol in the middle and late stages of acid production. L -1 h -1 glutaric acid real-time fermentation process parameter diagram.
图6为流加50%硫酸铵溶液,控制硫酸铵流加速度,使得产酸期OUR、CER分别在60–80mmol L-1h-1和80–10m mol L-1h-1两种方案时的发酵过程戊二酸产酸速率曲线和菌体生长曲线图。Figure 6 shows the two scenarios of feeding 50% ammonium sulfate solution and controlling the ammonium sulfate flow acceleration so that the acid production period OUR and CER are 60–80mmol L -1 h -1 and 80–10m mol L -1 h -1 respectively. Glutaric acid acid production rate curve and bacterial growth curve during the fermentation process.
图7为流加50%硫酸铵溶液,控制硫酸铵流加速度,使得产酸期到发酵结束的OUR、CER保持在160–180m mol L-1h-1的戊二酸实时发酵过程参数图。Figure 7 is a parameter diagram of glutaric acid real-time fermentation process in which 50% ammonium sulfate solution is added and the ammonium sulfate flow acceleration is controlled to maintain the OUR and CER at 160–180m mol L -1 h -1 from the acid production period to the end of fermentation.
具体实施方式Detailed ways
下面结合具体实施例,进一步阐述本发明。应理解,这些实施例仅用于说明本发明而不用于限制本发明的范围。此外应理解,在阅读了本发明讲授的内容之后,本领域技术人员可以对本发明作各种改动或修改,这些等价形式同样落于本申请所附权利要求书所限定的范围。The present invention will be further described below in conjunction with specific embodiments. It should be understood that these examples are only used to illustrate the invention and are not intended to limit the scope of the invention. In addition, it should be understood that after reading the teachings of the present invention, those skilled in the art can make various changes or modifications to the present invention, and these equivalent forms also fall within the scope defined by the appended claims of this application.
实施例1Example 1
基于微生物生理参数OUR、CER进行反馈调控氨水流加速度Feedback control of ammonia water flow acceleration based on microbial physiological parameters OUR and CER
采用本实验室构建的代谢工程菌株Escherichia coli LQ-1进行戊二酸发酵,构建方法参考文献用常规方法进行,主要通过将来自于恶臭假单胞菌的的赖氨酸2-单加氧酶(DavB)编码基因和δ-氨基戊酰胺酶(DavA)编码基因的质粒转入宿主菌,并进一步通过质粒过表达5-氨基戊酸氨基转移酶(GabT)和琥珀酸半醛脱氢酶(GabD。发酵具体工艺如下:The metabolic engineering strain Escherichia coli LQ-1 constructed in our laboratory was used for glutaric acid fermentation. The construction method was carried out by conventional methods according to the literature, mainly by adding lysine 2-monooxygenase from Pseudomonas putida. The plasmids encoding genes for (DavB) and δ-aminovaleramidase (DavA) were transferred into the host bacteria, and 5-aminovalerate aminotransferase (GabT) and succinate semialdehyde dehydrogenase (GabT) were further overexpressed through the plasmids. GabD. The specific fermentation process is as follows:
(1)甘油管自然解冻后,用消毒后的枪头取300uL于平板培养基上,尽量铺开,37℃恒温培养箱倒置培养24h。活化培养基为:4g/L磷酸二氢钾、0.5g/L七水硫酸镁、4.5g/L硫酸铵、5g/L酵母粉、8g/L蛋白胨、3g/L蔗糖、50μg/mL氨苄青霉素、50μg/mL氯霉素。(1) After the glycerol tube is naturally thawed, use a sterilized pipette tip to take 300uL on the plate culture medium, spread it out as much as possible, and incubate it upside down in a 37°C constant-temperature incubator for 24 hours. The activation medium is: 4g/L potassium dihydrogen phosphate, 0.5g/L magnesium sulfate heptahydrate, 4.5g/L ammonium sulfate, 5g/L yeast powder, 8g/L peptone, 3g/L sucrose, 50μg/mL ampicillin , 50μg/mL chloramphenicol.
(2)平板上菌落形成菌苔,用接种环取整个平板菌体于种子摇瓶中,37℃,170rpm摇床培养7h后,接种一级种子罐。摇瓶培养基配方同平板培养基。(2) The bacterial colonies on the plate form a bacterial lawn. Use an inoculating loop to take the entire bacterial plate and place it in a seed shaker flask. After culturing on a shaker at 37°C and 170rpm for 7 hours, inoculate the first-level seed tank. The formula of shake flask culture medium is the same as that of plate culture medium.
(3)种子罐工艺:接种量0.1%,通风量0.4vvm,搅拌转速300–600rpm,罐压0.05–0.08MPa,培养过程中控制DO>5%,25%的氨水控制发酵过程pH值6.7,37℃,培养16–18h,OD600达到0.8–1.0(稀释25倍)后,接种于30L发酵罐。一级种子罐培养基为:6g/L磷酸二氢钾、0.5g/L七水硫酸镁、3g/L硫酸铵、4g/L酵母粉、6g/L蛋白胨、40g/L葡萄糖、50μg/mL氨苄青霉素、50μg/mL氯霉素。(3) Seed tank technology: inoculation amount 0.1%, ventilation volume 0.4vvm, stirring speed 300–600rpm, tank pressure 0.05–0.08MPa, control DO>5% during the culture process, 25% ammonia water controls the pH value of the fermentation process to 6.7, Incubate at 37°C for 16-18 hours. After the OD 600 reaches 0.8-1.0 (diluted 25 times), inoculate it into a 30L fermenter. The first-level seed tank culture medium is: 6g/L potassium dihydrogen phosphate, 0.5g/L magnesium sulfate heptahydrate, 3g/L ammonium sulfate, 4g/L yeast powder, 6g/L peptone, 40g/L glucose, 50μg/mL Ampicillin, 50μg/mL chloramphenicol.
(4)发酵工艺:接种量14%,搅拌转速和DO关联,使得发酵过程中DO20%–40%,罐压0.05–0.1MPa,通风量0.4–0.6vvm,控制发酵温度为37℃,发酵过程pH值维持在6.7,发酵过程中,流加70%的葡萄糖溶液,并控制发酵液残糖浓度在0.5–1%,发酵周期为60h。发酵培养基:1.6g/L七水硫酸镁、0.03g/L七水硫酸亚铁、0.032g/L一水硫酸锰、10g/L硫酸铵、磷酸二氢钾5g/L、30g/L葡萄糖、25g/L玉米浆,2.2g/L甜菜碱,0.006g/L维生素B1、50μg/mL氨苄青霉素、50μg/mL氯霉素。(4) Fermentation process: the inoculation amount is 14%, the stirring speed is related to DO, so that during the fermentation process, DO is 20%–40%, the tank pressure is 0.05–0.1MPa, the ventilation volume is 0.4–0.6vvm, and the fermentation temperature is controlled to 37°C. The pH value is maintained at 6.7. During the fermentation process, 70% glucose solution is added, and the residual sugar concentration of the fermentation liquid is controlled at 0.5-1%. The fermentation cycle is 60 hours. Fermentation medium: 1.6g/L magnesium sulfate heptahydrate, 0.03g/L ferrous sulfate heptahydrate, 0.032g/L manganese sulfate monohydrate, 10g/L ammonium sulfate, 5g/L potassium dihydrogen phosphate, 30g/L glucose , 25g/L corn steep liquor, 2.2g/L betaine, 0.006g/L vitamin B1, 50μg/mL ampicillin, 50μg/mL chloramphenicol.
采用两种氨水流加策略:Two ammonia water addition strategies are used:
种子接入30L发酵罐进行发酵,当OUR、CER达到140m mol L-1h-1时,启动氨水流加,氨水的流加速度根据实时的OUR和CER,使得产酸期OUR和CER保持在60–80m mol L-1h-1;The seeds are connected to the 30L fermentation tank for fermentation. When OUR and CER reach 140m mol L -1 h -1 , the ammonia water flow is started. The ammonia flow acceleration is based on the real-time OUR and CER, so that the OUR and CER during the acid production period are maintained at 60 –80m mol L -1 h -1 ;
种子接入30L发酵罐进行发酵,当OUR、CER达到140m mol L-1h-1时,启动氨水流加,用30%氢氧化钠溶液调控发酵液的pH值,氨水的流加速度根据实时的OUR和CER,使得产酸期OUR和CER保持在120–140m mol L-1h-1,两种方案的发酵过程实时参数如图1和图2所示。发酵进行60h,发酵结果如表1所示。The seeds are connected to the 30L fermentation tank for fermentation. When OUR and CER reach 140m mol L -1 h -1 , the ammonia flow is started to be added, and 30% sodium hydroxide solution is used to adjust the pH value of the fermentation liquid. The ammonia flow acceleration is based on the real-time OUR and CER, so that OUR and CER during the acid production period are maintained at 120–140m mol L -1 h -1 . The real-time parameters of the fermentation process of the two schemes are shown in Figures 1 and 2. The fermentation was carried out for 60 hours, and the fermentation results are shown in Table 1.
表1不同调控策略对应的戊二酸发酵结果比较Table 1 Comparison of glutaric acid fermentation results corresponding to different control strategies
实施例2Example 2
基于微生物生理参数OUR、CER进行反馈调控硫酸铵溶液流加速度Feedback control of ammonium sulfate solution flow acceleration based on microbial physiological parameters OUR and CER
按照实施例1的流程和方法,不同处是采用流加50%的硫酸铵提供戊二酸合成的氮源,用30%氢氧化钠溶液调控发酵液的pH值。氮源流加速度根据实时的OUR、CER进行反馈调节,共三种方案:According to the process and method of Example 1, the difference is that 50% ammonium sulfate is used to provide a nitrogen source for glutaric acid synthesis, and 30% sodium hydroxide solution is used to control the pH value of the fermentation broth. The nitrogen source flow acceleration is feedback adjusted based on the real-time OUR and CER. There are three options:
Scheme1:种子接入30L发酵罐进行发酵,当OUR、CER达到140m mol L-1h-1时,启动氨水流加,硫酸铵溶液的流加速度根据实时的OUR和CER,使得产酸前期OUR和CER保持在160–180m mol L-1h-1,产酸中后期OUR和CER保持在60–80m mol L-1h-1。Scheme1: The seeds are connected to the 30L fermentation tank for fermentation. When OUR and CER reach 140m mol L -1 h -1 , the ammonia water flow is started. The flow acceleration of the ammonium sulfate solution is based on the real-time OUR and CER, so that the OUR and CER in the early stage of acid production are CER was maintained at 160–180m mol L -1 h -1 , and OUR and CER were maintained at 60–80m mol L -1 h -1 in the middle and late stages of acid production.
Scheme2:种子接入30L发酵罐进行发酵,当OUR、CER达到140m mol L-1h-1时,启动氨水流加,硫酸铵溶液的流加速度根据实时的OUR和CER,使得产酸前期OUR和CER保持在140–160m mol L-1h-1,产酸中后期OUR和CER保持在80–100m mol L-1h-1。Scheme 2: The seeds are connected to the 30L fermenter for fermentation. When OUR and CER reach 140m mol L -1 h -1 , the ammonia water flow is started. The flow acceleration of the ammonium sulfate solution is based on the real-time OUR and CER, so that the OUR and CER in the early stage of acid production are CER was maintained at 140–160m mol L -1 h -1 , and OUR and CER were maintained at 80–100m mol L -1 h -1 in the middle and late stages of acid production.
Scheme3:种子接入30L发酵罐进行发酵,当OUR、CER达到140m mol L-1h-1时,启动氨水流加,硫酸铵溶液的流加速度根据实时的OUR和CER,使得产酸期OUR和CER保持在160–180m mol L-1h-1。Scheme 3: The seeds are connected to the 30L fermentation tank for fermentation. When OUR and CER reach 140m mol L -1 h -1 , the ammonia water flow is started. The flow acceleration of the ammonium sulfate solution is based on the real-time OUR and CER, so that the acid production period OUR and The CER remains at 160–180m mol L -1 h -1 .
三种方案的发酵过程实时参数如图4、5、7所示。如图4、5、6说明,当采用高的OUR、CER来反馈调控氮源流加速度时,戊二酸产酸速率更快。按照Scheme3进行氮源流加速度调控,发酵进行60h,发酵液中戊二酸产率和糖酸转化率最高,分别为53.65g/L和46.76%。The real-time parameters of the fermentation process of the three schemes are shown in Figures 4, 5, and 7. As shown in Figures 4, 5, and 6, when high OUR and CER are used to feedback control the nitrogen source flow acceleration, glutaric acid produces acid at a faster rate. The nitrogen source flow acceleration was controlled according to Scheme 3, and the fermentation was carried out for 60 hours. The glutaric acid yield and sugar acid conversion rate in the fermentation broth were the highest, which were 53.65g/L and 46.76% respectively.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210426003.6A CN114921502B (en) | 2022-04-21 | 2022-04-21 | Glutaric acid production method for feedback regulation and control of nitrogen source flow based on microorganism physiological parameters |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210426003.6A CN114921502B (en) | 2022-04-21 | 2022-04-21 | Glutaric acid production method for feedback regulation and control of nitrogen source flow based on microorganism physiological parameters |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114921502A CN114921502A (en) | 2022-08-19 |
CN114921502B true CN114921502B (en) | 2023-10-20 |
Family
ID=82806553
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210426003.6A Active CN114921502B (en) | 2022-04-21 | 2022-04-21 | Glutaric acid production method for feedback regulation and control of nitrogen source flow based on microorganism physiological parameters |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114921502B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115948622B (en) * | 2022-09-22 | 2024-08-09 | 北京蓝晶微生物科技有限公司 | Microbial fermentation control method, device, system, equipment and medium |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6284453B1 (en) * | 1999-09-29 | 2001-09-04 | Steven Anthony Siano | Method for controlling fermentation growth and metabolism |
CN109136295A (en) * | 2018-08-17 | 2019-01-04 | 北京化工大学 | A kind of method of biosynthesis glutaric acid |
CN110468167A (en) * | 2018-05-04 | 2019-11-19 | 上海凯赛生物技术股份有限公司 | A kind of method of fermenting and producing 1,5- pentanediamine |
CN112226398A (en) * | 2020-10-30 | 2021-01-15 | 江南大学 | A kind of recombinant Escherichia coli for efficiently producing glutaric acid and construction method thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102108021B1 (en) * | 2018-08-23 | 2020-05-07 | 한국화학연구원 | Recombinant Corynebacterium glutamicum strain for producing glutaric acid and a method of producing glutaric acid using the same |
-
2022
- 2022-04-21 CN CN202210426003.6A patent/CN114921502B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6284453B1 (en) * | 1999-09-29 | 2001-09-04 | Steven Anthony Siano | Method for controlling fermentation growth and metabolism |
CN110468167A (en) * | 2018-05-04 | 2019-11-19 | 上海凯赛生物技术股份有限公司 | A kind of method of fermenting and producing 1,5- pentanediamine |
CN109136295A (en) * | 2018-08-17 | 2019-01-04 | 北京化工大学 | A kind of method of biosynthesis glutaric acid |
CN112226398A (en) * | 2020-10-30 | 2021-01-15 | 江南大学 | A kind of recombinant Escherichia coli for efficiently producing glutaric acid and construction method thereof |
Non-Patent Citations (3)
Title |
---|
A bio-based route to the carbon-5 chemical glutaric acid and to bionylon-6,5 using metabolically engineered Corynebacterium glutamicum;Christina Maria Rohles等;Green Chemistry;第20卷;第4662-4674页 * |
Elmar Heinzle等.BiologicalReaction Engineering: DynamicModeling FundamentalsWith 80 Interactive Simulation Examples.WILEY-VCH GmbH,2021,(第3版),第143-157页. * |
新一代工业微生物生物网络模型的构建及应用;叶超;中国博士学位论文全文数据库 基础科学辑;A006-75 * |
Also Published As
Publication number | Publication date |
---|---|
CN114921502A (en) | 2022-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sugimoto et al. | Control of acetic acid concentration by pH‐stat continuous substrate feeding in heterotrophic culture phase of two‐stage cultivation of Alcaligenes eutrophus for production of P (3HB) from CO2, H2, and O2 under non‐explosive conditions | |
KR20100109902A (en) | Large scale microbial culture method | |
CN114921502B (en) | Glutaric acid production method for feedback regulation and control of nitrogen source flow based on microorganism physiological parameters | |
CN102604904B (en) | Production method of glucose dehydrogenase | |
CN115637276B (en) | Method for producing tetrahydropyrimidine by using halomonas strain | |
CN101967501B (en) | Method for producing lysine by feedback supplement based on pH | |
CN113493761B (en) | A kind of fermentation technology that improves the output of 5-hydroxytryptophan | |
Huang et al. | Redirecting carbon flux in Torulopsis glabrata from pyruvate to α-ketoglutaric acid by changing metabolic co-factors | |
CN109536542A (en) | The preparation method of 1,5- pentanediamine | |
CN117535330A (en) | Recombinant escherichia coli for efficiently producing L-homoserine, construction method and application thereof | |
CN110468167B (en) | Method for producing 1, 5-pentanediamine by fermentation | |
CN114058654B (en) | Fermentation method for increasing yield of gamma-aminobutyric acid | |
CN102747114B (en) | Method for regulating recombinant escherichia coli metabolism by using transient anaerobic fermentation | |
CN114606275B (en) | Method for producing L-isoleucine through fermentation | |
CN116426577A (en) | Calcium hydroxide as neutralizer combined with CO 2 Method for producing succinic acid by pulse feedback feed supplement fermentation | |
CN109207534A (en) | A method of improving L-Methionine yield | |
JP3074781B2 (en) | Production method of L-lysine by fermentation method | |
CN110885774A (en) | Method for optimizing glutamic acid fermentation | |
GB2147580A (en) | Improved process for producing L-amino acids from alpha-keto acids by fed-batch fermentation | |
CN113862315B (en) | Formula for producing L-phenylalanine by escherichia coli fermentation and application thereof | |
CN117946954B (en) | Leucine production strain, construction method and application thereof | |
CN117025496B (en) | Escherichia coli fermentation method of recombinant plasmid, culture medium system and application of culture medium system | |
CN114875090B (en) | Method for producing lysine and application thereof | |
CN1446913A (en) | Technique method for preparing hydratase of carbonitrile mitrile by using glucose-CO2+ coupling adding ferment | |
CN118995551A (en) | Bacillus licheniformis for producing gamma-aminobutyric acid by fermentation method, construction method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |